An introduction from  32
our management
- Chairman’s Statement Those dimensions also correspond to the 4 specific purposes of common bene-
- Letter from the CEO
fit that we have elected since becoming a Benefit Corporation. 
01
Chiesi at a Glance
We are committed to implementing the necessary actions to reach the objecti-
ves set out in the selected areas. In the following pages, we want to share the 
02
Positive Impacts  positive effects achieved through the actions implemented and the efforts  s
e
and Challenges g
put in place by Chiesi at the global level, that go well beyond KPIs and mea- n
- Products and Patients le
l
- Processes surable objectives. a
h
- Global Value Chain c
- Corporate Citizenship nd 
a
s 
03 ct
a
Chiesi’s contribution  p
to the UN Sustainable  1. Products and Patients m
i
Development Goals e 
v
i
t
i
s
04 o
P
Annexes Associated purpose of common benefit:  Positive effects generated in 2019:
- Impact Report
- Data, Methodology 
   and GRI Content Index
Improving patients’ and peoples’ lives,  •  Improving patients’ health
aiming to improve their health, wel- •  Fostering Research & Development
lbeing and quality of life. and substantially contributing to
the scientific progress
2. Processes
Associated purpose of common benefit:  Positive effects generated in 2019:
Continuous  innovation  towards  the  •  Ensuring regular supply of high quali-
sustainability  of  processes  and  all  ty medicinal products for the patien-
company practices in order to minimi- ts in need
se negative impacts, in favour of po- •  Lowering our impact on the biosphere
sitive ones, on people, the biosphere •  Fostering the self-fulfilment and wel-
and on the territory. lbeing of the Chiesi people
•  Guaranteeing  a  safe  and  healthy 
working place for our employees